Overexpression of POLQ confers a poor prognosis in early breast cancer patients.

Oncotarget

Volumn 1, Issue 3, 2010, Pages 175-184

  Higgins, Geoff S ^a   Harris, Adrian L ^b   Prevo, Remko ^b   Helleday, Thomas ^b   McKenna, W Gillies ^b   Buffa, Francesca M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE; DNA POLYMERASE THETA;

ARTICLE; BREAST TUMOR; DISEASE COURSE; DNA REPAIR; DRUG EFFECT; FEMALE; FOLLOW UP; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME;

BREAST NEOPLASMS; DISEASE PROGRESSION; DNA REPAIR; DNA-DIRECTED DNA POLYMERASE; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; MOLECULAR TARGETED THERAPY; PROGNOSIS; RADIATION TOLERANCE; TREATMENT OUTCOME;

EID: 79251525596     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.124     Document Type: Article

References (0)